Overview
Description
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. The firm also offers clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. The firm operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices Japan
Financials
Key metrics
Market capitalisation, EUR | 10,210.06 m |
EPS, EUR | 0.57 |
P/B ratio | 3.61 |
P/E ratio | 28.88 |
Dividend yield | 1.12% |
Income statement (2023)
Revenue, EUR | 2,949.52 m |
Net income, EUR | 317.24 m |
Profit margin | 10.76% |
What ETF is Sysmex Corp. in?
There are 288 ETFs which contain Sysmex Corp.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Sysmex Corp. is the BNP Paribas Easy MSCI Japan SRI S-Series PAB 5% Capped UCITS ETF EUR Dis.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.